File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/nrdp.2016.67
- Scopus: eid_2-s2.0-84988880031
- PMID: 27654570
- WOS: WOS:000384877400001
Supplementary
- Citations:
- Appears in Collections:
Article: Primary open-angle glaucoma
Title | Primary open-angle glaucoma |
---|---|
Authors | |
Issue Date | 2016 |
Citation | Nature Reviews Disease Primers, 2016, v. 2, article no. 16067 How to Cite? |
Abstract | Glaucoma is an optic neuropathy that is characterized by the progressive degeneration of the optic nerve, leading to visual impairment. Glaucoma is the main cause of irreversible blindness worldwide, but typically remains asymptomatic until very severe. Open-angle glaucoma comprises the majority of cases in the United States and western Europe, of which, primary open-angle glaucoma (POAG) is the most common type. By contrast, in China and other Asian countries, angle-closure glaucoma is highly prevalent. These two types of glaucoma are characterized based on the anatomic configuration of the aqueous humour outflow pathway. The pathophysiology of POAG is not well understood, but it is an optic neuropathy that is thought to be associated with intraocular pressure (IOP)-related damage to the optic nerve head and resultant loss of retinal ganglion cells (RGCs). POAG is generally diagnosed during routine eye examination, which includes fundoscopic evaluation and visual field assessment (using perimetry). An increase in IOP, measured by tonometry, is not essential for diagnosis. Management of POAG includes topical drug therapies and surgery to reduce IOP, although new therapies targeting neuroprotection of RGCs and axonal regeneration are under development. |
Persistent Identifier | http://hdl.handle.net/10722/298175 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Weinreb, Robert N. | - |
dc.contributor.author | Leung, Christopher K.S. | - |
dc.contributor.author | Crowston, Jonathan G. | - |
dc.contributor.author | Medeiros, Felipe A. | - |
dc.contributor.author | Friedman, David S. | - |
dc.contributor.author | Wiggs, Janey L. | - |
dc.contributor.author | Martin, Keith R. | - |
dc.date.accessioned | 2021-04-08T03:07:50Z | - |
dc.date.available | 2021-04-08T03:07:50Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | Nature Reviews Disease Primers, 2016, v. 2, article no. 16067 | - |
dc.identifier.uri | http://hdl.handle.net/10722/298175 | - |
dc.description.abstract | Glaucoma is an optic neuropathy that is characterized by the progressive degeneration of the optic nerve, leading to visual impairment. Glaucoma is the main cause of irreversible blindness worldwide, but typically remains asymptomatic until very severe. Open-angle glaucoma comprises the majority of cases in the United States and western Europe, of which, primary open-angle glaucoma (POAG) is the most common type. By contrast, in China and other Asian countries, angle-closure glaucoma is highly prevalent. These two types of glaucoma are characterized based on the anatomic configuration of the aqueous humour outflow pathway. The pathophysiology of POAG is not well understood, but it is an optic neuropathy that is thought to be associated with intraocular pressure (IOP)-related damage to the optic nerve head and resultant loss of retinal ganglion cells (RGCs). POAG is generally diagnosed during routine eye examination, which includes fundoscopic evaluation and visual field assessment (using perimetry). An increase in IOP, measured by tonometry, is not essential for diagnosis. Management of POAG includes topical drug therapies and surgery to reduce IOP, although new therapies targeting neuroprotection of RGCs and axonal regeneration are under development. | - |
dc.language | eng | - |
dc.relation.ispartof | Nature Reviews Disease Primers | - |
dc.title | Primary open-angle glaucoma | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1038/nrdp.2016.67 | - |
dc.identifier.pmid | 27654570 | - |
dc.identifier.scopus | eid_2-s2.0-84988880031 | - |
dc.identifier.volume | 2 | - |
dc.identifier.spage | article no. 16067 | - |
dc.identifier.epage | article no. 16067 | - |
dc.identifier.eissn | 2056-676X | - |
dc.identifier.isi | WOS:000384877400001 | - |
dc.identifier.issnl | 2056-676X | - |